Drug Type Universal CAR-T |
Synonyms- |
Target |
Mechanism NCR2 modulators(natural cytotoxicity triggering receptor 2 modulators), NKG2D modulators(NKG2-D type II integral membrane protein modulators), Immunologic cytotoxicity + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 23 May 2023 |